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Abstract
Bacterial superantigens (SAg) stimulate T-cell hyper-activation resulting in immune modulation and severe systemic
illnesses such as Staphylococcus aureus toxic shock syndrome. However, all known S. aureus SAgs are encoded by mobile
genetic elements and are made by only a proportion of strains. Here, we report the discovery of a novel SAg staphylococcal
enterotoxin-like toxin X (SElX) encoded in the core genome of 95% of phylogenetically diverse S. aureus strains from human
and animal infections, including the epidemic community-associated methicillin-resistant S. aureus (CA-MRSA) USA300
clone. SElX has a unique predicted structure characterized by a truncated SAg B-domain, but exhibits the characteristic
biological activities of a SAg including Vb-specific T-cell mitogenicity, pyrogenicity and endotoxin enhancement. In addition,
SElX is expressed by clinical isolates in vitro, and during human, bovine, and ovine infections, consistent with a broad role in
S. aureus infections of multiple host species. Phylogenetic analysis suggests that the selx gene was acquired horizontally by
a progenitor of the S. aureus species, followed by allelic diversification by point mutation and assortative recombination
resulting in at least 17 different alleles among the major pathogenic clones. Of note, SElX variants made by human- or
ruminant-specific S. aureus clones demonstrated overlapping but distinct Vb activation profiles for human and bovine
lymphocytes, indicating functional diversification of SElX in different host species. Importantly, SElX made by CA-MRSA
USA300 contributed to lethality in a rabbit model of necrotizing pneumonia revealing a novel virulence determinant of CA-
MRSA disease pathogenesis. Taken together, we report the discovery and characterization of a unique core genome-
encoded superantigen, providing new insights into the evolution of pathogenic S. aureus and the molecular basis for severe
infections caused by the CA-MRSA USA300 epidemic clone.
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Introduction
Staphylococcus aureus is responsible for an array of diseases
including life-threatening toxinoses such as toxic shock syndrome
(TSS) and necrotizing pneumonia. Many strains of S. aureus have
been shown to produce members of a family of more than 20
serologically distinct superantigenic (SAg) toxins, which contribute
to disease pathogenesis via modulation of the host immune
response [1,2]. Previously characterized SAgs are small secreted
proteins of 20 to 28 kDa in size, which share similar biochemical,
structural, and immunobiological properties [1,2], but can be
differentiated into 4 distinct subgroups according to their
phylogenetic relatedness [3–5]. They share a compact 2-domain
protein structure consisting of domain A which contains a long
central a-helix and a C-terminal b-grasp motif, and the smaller
domain B which contains an N-terminal oligonucleotide-oligosac-
charide binding (OB) fold [1,2,5,6]. SAgs bypass the conventional
antigen processing pathway, by binding simultaneously to MHC
class II molecules of antigen-presenting cells, outside of the
antigen-binding groove, and the variable region of the T-cell
receptor (TCR) b-chain (Vb) [7,8]. In so doing, SAgs can react
with all T-cells expressing reactive Vb-TCR regions (up to 50%),
instead of the normal responding frequency to an antigen of
approximately 0.01%, resulting in massive inflammatory cytokine
release and consequent toxic shock [9]. SAgs also have the
capacity to cause immune suppression by inducing T-cell anergy,
and may contribute to bacterial persistence during chronic
infection [10].
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All staphylococcal SAgs identified to date are encoded by
mobile genetic elements (MGE) such as plasmids, phages,
transposons and S. aureus pathogenicity islands (SaPIs), or the
highly variable genomic region vSab [4,11–14]. Accordingly, the
distribution of SAg genes is S. aureus strain-dependent. For
example, Omoe et al. reported that 80% of human isolates contain
at least one SAg gene, including 50% which contain the
enterotoxin gene cluster (egc) locus, and Smyth et al. demonstrated
that 57% of animal strains examined contained at least one SAg
gene with the egc found in 30% of isolates [15,16]. These data
collectively suggest that no single SAg is encoded by more than
50% of strains and that some strains may not have superantigenic
capacity at all. The USA300 S. aureus clone which is responsible for
the current CA-MRSA epidemic affecting the USA and other
countries is typically associated with skin and soft tissue infections
and has the capacity to cause lethal toxinoses such as necrotizing
pneumonia and extreme pyrexia [17–19]. However, USA300
strains do not typically produce TSST-1 or staphylococcal
enterotoxins B and C, the SAgs most often associated with toxic
shock [20,21]. Here, we report the discovery of a unique core
genome-encoded SAg (designated SElX), encoded by the great
majority of S. aureus strains, determine its immunobiological
function and examine its molecular evolution. Our data suggest
that SElX contributes to immune modulation in both human and
animal disease pathogenesis, and demonstrate a role for SElX in
the development CA-MRSA USA300 necrotizing pneumonia in a
rabbit model of infection.
Results
Identification of a novel putative SAg gene encoded by
the great majority of S. aureus strains
In order to examine the superantigenic capacity of the epidemic
CA-MRSA clone, USA300, we carried out a genome-wide screen
of USA300 strain FPR3757 to identify genes encoding proteins
with homology to known SAgs [21]. In addition to characterized
SAgs, SElK and SElQ, we discovered a SAg gene homolog,
SAUSA300_0370 which encodes a protein with 24% amino acid
identity to the major virulence factor, TSST-1 and 27% identity
with the SAg-like protein, SSL7. The gene, designated selx
encoding staphylococcal enterotoxin-like toxin X (SElX), is 612
bp in length and is most closely-related to the phylogenetic group
IV of staphylococcal SAgs represented by TSST-1, closely allied to
the staphylococcal SAg-like (SSL) protein family (Fig. 1a). The
mature form of SElX is 168 amino acids in length with a predicted
molecular weight of 19343 Da, smaller than any known
staphylococcal SAg [1,4]. In order to examine the distribution of
selx among S. aureus strains, we screened a total of 114 isolates by a
combination of bioinformatic interrogation of 53 publicly available
S. aureus genome sequences (Table S1), and PCR analysis using
selx-specific oligonucleotide primers (Table S2) of a further 61 S.
aureus isolates selected to represent the full breadth of species
diversity and to include the most important human and animal
pathogenic clones (Table S3). Remarkably, 108 of the 114 isolates
(95%) contained the selx gene which included all strains examined
except isolates of the CC30 clonal complex (Fig. 1b; Table S1 and
S3).
Analysis of the location of selx in the genomes of strains
representing diverse multi-locus sequence types (ST)s, including
MSSA476 (ST1), N315 (ST5), USA300 TCH3757 (ST8), H19
(ST10), A9635 (ST45slv), TCH130 (ST72), JKD6159 (ST93), JH1
(ST105), ED133 (ST133), RF122 (ST151), 04–02891 (ST225),
JKD6008 (ST239), COL (ST250) and TCH959 (ST1159),
revealed that selx is located at an identical chromosomal site in
all strains examined (Fig. S1). Specifically, it is located ,400 kb
from the origin of replication in the oriC environ among a cluster of
4 genes specific for the S. aureus species including 2 genes encoding
hypothetical proteins of unknown function, and a predicted
integrase pseudogene which contains partial homology to an
integrase encoded by the S. aureus bacteriophage, PT1028 [22].
The gene cluster is flanked by conserved genes encoding ribosomal
proteins and a DNA-binding protein involved in DNA replication,
which are located at the same genomic location in other
staphylococcal species such as Staphylococcus epidermidis (Fig. S1).
The genetic linkage of selx with an integrase pseudogene, its wide
distribution across the full breadth of S. aureus species diversity, and
its absence in the genomes of other staphylococcal species indicates
an ancient horizontal acquisition which may have occurred during
S. aureus speciation. The existence of a single S. aureus clonal
complex (CC30), which does not contain selx but contains the
adjacent integrase pseudogene at the same chromosomal site, is
consistent with a deletion event in a progenitor of the clonal
lineage which contained the selx gene (Fig. S1).
selx exhibits considerable species-wide allelic variation
and evidence for assortative recombination
In order to examine the allelic variation of selx among S. aureus
strains representing the breadth of species diversity, DNA
sequencing of selx was carried out for 11 S. aureus strains
representative of ST 9, 12, 15, 25, 45, 97, 121, and 126 and
compared to the sequence of selx for 49 strains available in
Genbank (Table S1). selx was represented by 17 distinct allelic
variants encoded by human and animal strains, designated selx1-
14, selxbov1-2, and selxov, respectively. Novel nucleotide sequences
for selx8-11 and selxbov2 have been deposited in GenBank under
accession numbers HQ850970, HQ850971, HQ850968,
HQ850969 and HQ85097, respectively. Of note, the human
ST398 strain OS385 contains selx13, which is a 315 bp truncated
C-terminal fragment of the gene predicted to be non-functional.
With the exception of the truncated selx13 there are 85.9% non-
variable nucleotide sites among the selx alleles identified. This
corresponds to a total of 40 (13%) variable amino acid residues
among the 204 amino acid sites of SElX (Fig. S2). Pairwise amino
acid alignment reveals 89.5 to 98.5% amino acid identity among
Author Summary
Staphylococcus aureus is a global pathogen, responsible for
an array of different illnesses in humans and animals. In
particular, community-associated methicillin-resistant S.
aureus (CA-MRSA) strains of the pandemic USA300 clone
have the capacity to cause lethal human necrotizing
pneumonia, but the molecular basis for the enhanced
virulence remains unclear. Bacterial superantigens (SAg)
stimulate T-cell hyper-activation resulting in severe sys-
temic illnesses such as toxic shock syndrome (TSS).
However, all S. aureus SAgs identified to date are encoded
by mobile genetic elements found only in a proportion of
clinical isolates. Here, we report the discovery of a unique
core genome-encoded SAg (SElX) which was acquired by
an ancestor of the S. aureus species and which has
undergone genetic and functional diversification in
pathogenic clones infecting humans and animals. Impor-
tantly, we report that SElX made by pandemic USA300
contributes to lethality in a rabbit model of human
necrotizing pneumonia revealing a novel virulence deter-
minant of severe CA-MRSA infection.
CA-MRSA Core Genome-Encoded Superantigen
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the different allelic variants made by the major S. aureus pathogenic
clones (Fig. S2).
In general, each clonal complex (consisting of closely-related
STs) contains a unique selx allele (Fig. 1b) consistent with point
mutation being the major driving force for evolution within
individual lineages. However, allele selx2 was identified in ST12,
ST15 and CC8 strains, and selx5 was encoded by both ST1 and
ST72 strains, respectively, indicating that assortative recombina-
tion of the selx gene has contributed to its distribution among some
lineages which have not shared a recent common ancestor
Figure 2. SElX is expressed by clinical isolates in vitro and during infection. a) Growth-phase dependent transcription of selx determined by
qRT-PCR. b). Representative Western blot analysis of rSElX proteins with human infective endocarditis (IE) or ovine mastitis sera samples.
doi:10.1371/journal.ppat.1002271.g002
Figure 1. Phylogenetic analysis of selx and its species-wide distribution. a) Neighbor-joining tree based on the sequences of all known
staphylococcal SAgs and the SAg-like protein, SSL7 b) Neighbor-joining tree of concatenated MLST sequences of representative S. aureus STs
representing the breadth of species diversity. Coloured circles denote the presence of specific selx alleles.
doi:10.1371/journal.ppat.1002271.g001
CA-MRSA Core Genome-Encoded Superantigen
PLoS Pathogens | www.plospathogens.org 4 October 2011 | Volume 7 | Issue 10 | e1002271
(Fig. 1b). In addition, examination of the contribution of
recombination to selx diversity employing the RDP3 suite of
programs [23], revealed evidence for at least 3 distinct
recombination events leading to hybrid alleles of selx (Fig. S3).
Furthermore, a phylogenetic tree based on selx gene sequences had
a topology distinct from the phylogenetic tree derived from
Table 1. Immunoreactivity of recombinant SAg variants with sera from healthy humans, and bovine, ovine and human patients
recovering from S. aureus infections.
Serum sample SElXbov1 a SElXov a SElX2 a SElO a
Human (Normal)
HV093 n/d n/d + -
HVRC n/d n/d - +
HVJRF n/d n/d - -
HV100 n/d n/d - -
HV091 n/d n/d + -
HV126 n/d n/d + -
HV097 n/d n/d + -
HV101 n/d n/d + -
HV118 n/d n/d + -
HV115 n/d n/d + -
HV017 n/d n/d + -
HV105 n/d n/d + -
HV003 n/d n/d + -
HV008 n/d n/d + -
HV148 n/d n/d + -
HV139 n/d n/d + -
HV014 n/d n/d + -
HV047 n/d n/d + -
HV020 n/d n/d + -
HV057 n/d n/d + -
HV104 n/d n/d + -
HV002 n/d n/d + -
HV098 n/d n/d + -
Human IE
IE19 + + + -
IE37 + + + -
IE41 + + + -
Serum sample SElXbov1 a SElXov a SElX2 a SElO a
IE51 + + + -
IE54 + + + -
Bovine mastitis
2480 + + + -
2487 + + + -
2521 + + + -
4227 + + + -
2211 - - - -
Ovine mastitis
011 + + + -
040 + + + -
046 + + + -
0112 + + + -
0348 + + + -
a+, positive reactivity; -, negative reactivity; n/d, not done.
doi:10.1371/journal.ppat.1002271.t001
CA-MRSA Core Genome-Encoded Superantigen
PLoS Pathogens | www.plospathogens.org 5 October 2011 | Volume 7 | Issue 10 | e1002271
Figure 3. SElX is predicted to have a truncated B-domain. Schematic diagram of the solved structures of TSST-1, SSL7 and modelled 2-domain
structures of human, bovine and ovine variants of SElX. SElX composite structure was obtained by superimposition of protein variants in PyMol.
doi:10.1371/journal.ppat.1002271.g003
CA-MRSA Core Genome-Encoded Superantigen
PLoS Pathogens | www.plospathogens.org 6 October 2011 | Volume 7 | Issue 10 | e1002271
concatenated MLST loci (Fig. S4). Taken together, these data
suggest that recombination has contributed to the diversification
and distribution of selx among S. aureus clones.
SElX is expressed by clinical isolates in vitro and during
human, bovine and ovine infection
In order to determine whether selx was expressed by clinical
isolates we examined by quantitative real-time PCR (qRT-PCR),
the transcription of selx by human S. aureus CA-MRSA USA300
strain LAC, bovine strain RF122, and ovine strain ED133 during
exponential and stationary phases of growth in vitro. selx was
transcribed by each strain in a growth-phase dependent manner,
and the highest relative expression level was demonstrated by
USA300 strain LAC (Fig. 2). To investigate the in vitro expression
of SElX we carried out Western blot analysis with stationary phase
culture supernates of 15 representative clinical isolates of S. aureus
of human, bovine, and ovine origin, with rat anti-serum specific
for SElX. Expression of SElX was detected in 13 of 15 isolates
including 5 of 5 human isolates from sepsis, scalded skin syndrome
and infective endocarditis patients, 4 of 4 bovine mastitis isolates, 3
of 4 ovine mastitis isolates, and a single caprine mastitis isolate. A
single avian isolate ED98 did not express SElX in detectable
quantities. These data indicate that SElX is made by the majority
of clinical isolates at detectable levels in nutrient replete conditions
in vitro (Table S3).
To determine whether SElX is expressed during human and
animal colonization or infection, Western immunoblot analysis
was carried out using recombinant SElX human (SElX2), bovine
(SElXbov1) and ovine (SElXov) variants, with sera from humans,
cows and sheep recovering from S. aureus infections, and from
healthy human volunteers. Specific SElX antisera did not cross-
react with TSST-1 or SSL7, its closest homologs (Fig. S5). In
addition, we identified individuals who were seroconverted for
SElX but not for SSL7 or TSST-1, and an individual who was
seroconverted for SSL7 and TSST-1 but not for SElX (Fig. S5).
Taken together, these data indicate a lack of cross-reactivity of
antibodies specific for TSST-1, SSL7 and SElX. All 5 human, 4
bovine and 5 ovine serum samples from infected individuals, and
20 of 23 serum samples from healthy humans contained antibody
that recognized the SElX recombinant proteins, whereas only one
serum sample (from a healthy human) out of the total of 47
contained antibody that recognized recombinant SElO SAg
(Table 1). These data indicate that SElX is made during S. aureus
colonization or infection of humans and animals and stimulates a
humoral immune response. Of note, densitometric analysis of
SElX immuno-reactive bands indicated approximately 2-fold
lower reactivity of human IgG with recombinant SElXov, in
comparison to IgG from S. aureus-infected sheep, suggesting that
SElXov made by ovine S. aureus may vary antigenically (Fig. 2 b).
Overall, the expression of SElX during infection of humans and
animals suggests an important general role during S. aureus
infection of multiple host species.
SElX has a unique predicted SAg structure
The SElX2 variant encoded by S. aureus USA300 strain LAC,
contains 27% and 24% amino acid identity with its nearest protein
homologs, superantigen-like protein 7 (SSL7) and TSST-1,
respectively. In order to investigate the predicted structure of the
novel SAg, we carried out structural modeling using the program
Phyre [24] with SSL7 and TSST-1 crystal structures from the
PDB database as templates. Considering, the low sequence
homology of SElX with its closest homologs SSL7 and TSST-1,
used as templates for modeling, the results should be considered to
be speculative. The hypothetical predicted structures of SElX
variants imply a potential to form a characteristic 2 domain SAg
structure with some unusual features (Fig. 3). The predicted A-
domain containing the C-terminus has a long central a-helix,
positioned along one side of a 4-stranded b-sheet, forming a
structure typical of the b-grasp motif [25]. However the B-domain
which contains the N-terminus, is considerably smaller than the B-
domain of previously characterized SAgs and lacks an OB fold
(Fig. 3). The OB fold is the site typically involved in SAg binding to
the a-chain of the MHC class II complex on antigen presenting
cells [2,26]. The functional implications of this unique predicted
B-domain structure are currently unknown.
SElX is mitogenic and demonstrates Vb-dependent T-cell
proliferation
We examined the function of representative allelic variants of
SElX from human, bovine and ovine isolates. Recombinant
human (rSElX2), bovine (rSElXbov1), and ovine (rSElXov)
variants were purified and used to stimulate human PBMC in a
thymidine incorporation assay. All 3 rSElX variants were
mitogenic for human T-cells at concentrations above 0.1 ng/ml
(Fig. 4a). Further, in order to examine the mitogenicity of SElX
expressed in a native S. aureus background, selxbov1 was cloned into
the pALC2073 vector and expressed in a SAg-deficient strain
RF122-8. The supernatant from cultures of RF122-8 +
pALC2073:SElXbov1 had mitogenic activity for bovine lympho-
cytes, but supernatant from strain RF122-8 containing the
pALC2073 plasmid only had none (data not shown). SElX was
also mitogenic for rabbit lymphocytes and importantly, the
superantigenic activity of SElX for both human and rabbit T-
cells is comparable or higher to the activity of TSST-1, the SAg
responsible for the toxinoses toxic shock syndrome (TSS) (Fig. 4b,
c).
We recently designed a novel assay for quantifying human Vb
(humVb) gene expression including all of the known Vb subgroups
[27]. Previous studies of the bovine Vb (bovVb)-dependent
expansion capacity of staphylococcal SAgs have been restricted
by the number of identified bovine Vb subfamilies [11,28]. The
recent bovine genome sequencing project has facilitated a
comprehensive description of the bovine Vb subgroups and the
repertoire of functional Vb genes [29,30]. In the current study,
design of a novel bovVb-dependent expansion assay has allowed
us for the first time to evaluate the response of 23 human and 18
bovine Vb subfamilies to stimulation with a staphylococcal SAg
(Fig. 5a, b). rSElX2 and rSElXbov1 activated humVb subfamiles
1, 6, 18 and 21, whereas rSElXov activated 1, 6 and 18 but not 21
(Table 2). All SElX variants stimulated bovVb subfamily X. In
addition SElXov activated bovVb 16, SElXbov1 activated bovVb
3, 5, 11, 16 and 17, and SElX2 activated bovVb 5, 6, 17 and 24.
Different human and bovine Vb subfamilies are activated in
response to stimulation with SElX. This is in part due to the
activation of humVb subfamilies 18 and 21, for which there are no
bovine orthologs, and bovVb X which has no human ortholog.
However, the orthologous humVb 6 and bovVb 6 are both
activated by SElX2. In addition, bovVb subfamily 16 which is
activated by SElXbov1 and SElXov is phylogenetically related to
humVb 6. Of note, the humVb 1 subfamily and the closely related
bovVb 5 but not the orthologous bovVb 1 were activated by SElX
variants. These data indicate a unique pattern of Vb gene
activation for SElX in comparison to other previously character-
ized SAgs [3,27]. Importantly, the results demonstrate differences
in superantigenic activity and distinct Vb activation profiles for
different SElX variants made by S. aureus strains associated with
different host species.
CA-MRSA Core Genome-Encoded Superantigen
PLoS Pathogens | www.plospathogens.org 7 October 2011 | Volume 7 | Issue 10 | e1002271
CA-MRSA Core Genome-Encoded Superantigen
PLoS Pathogens | www.plospathogens.org 8 October 2011 | Volume 7 | Issue 10 | e1002271
SElX has functional activities characteristic of SAgs
We examined the ability of rSElX2 to cause TSS in rabbits
using a standard mini-osmotic pump model of TSS at a dose of
200 mg/kg. Of the 5 rabbits given rSElX2, 4 succumbed within
7 d, compared to 0 of 5 treated with PBS (p,0.05) (Fig. 6a). The
positive control TSST-1 was lethal for 3 of 3 animals in the 7 d test
period (Fig. 6a). Changes in temperature of the rabbits were
recorded before and 24 h post-SAg challenge. Rabbits treated
with rSElX2 developed fever with a 2.0uC increase in body
temperature over the 24 h test period, compared to 0.4uC for PBS
treated animals (p,0.001) (Fig. 6a).
Rabbits were also used to evaluate fever responses over 4 h after
intravenous injection, followed by the ability to enhance lethality
of LPS over a 48 h test period. The capacity to cause fever that
peaks 4 h after injection, and to amplify the lethal effects of LPS by
up to 106-fold are defining activities of SAgs. rSElX2 caused dose-
dependent fever responses in rabbits that peaked 4 h after
injection and the 4 h fever response of animals receiving 10 mg/
kg of rSElX2, compared to PBS, was significantly different (p value
of 0.001) (Fig. 6b). The minimum pyrogenic dose of SAg is defined
as the dose per kg required to cause an average 0.5uC rise in rabbit
body temperature in 3 animals; the minimum pyrogenic dose of
rSElX2 was calculated to be 1.0 mg/kg. rSElX2 also enhanced
rabbit susceptibility to lethal shock by LPS (Fig. 6b). Taken
together, rSElX2 demonstrated the functional characteristics
required for classification as a SAg, including mitogenicity,
pyrogenicity, enhancement of endotoxin shock, and lethality when
administered by mini-osmotic pump.
SElX contributes to lethality of CA MRSA USA300 in a
rabbit model of necrotizing pneumonia
CA-MRSA is notorious for causing skin and soft tissue
infections, and severe necrotizing pneumonia [20,31]. We found
that CA-MRSA USA300 strains expressed elevated levels of selx in
vitro relative to other clinical isolates (Fig. 2a). In order to
investigate the hypothesis that SElX contributes to the pathogen-
esis of necrotizing pneumonia, we constructed an SElX-deficient
mutant of CA-MRSA USA300 strain LAC (LAC Dselx), and a
repaired derivative with an intact functional selx gene (LAC Dselx
rep). To rule out the possibility of spurious mutations acquired
during the construction of LAC Dselx in loci which could influence
virulence, such as the accessory gene regulator (agr) [32], we
compared the isogenic LAC wild type, LAC Dselx and LAC Dselx
rep strains for hemolytic titre, secreted and cell wall-associated
protein profiles, and in vitro growth rate. In each case we found that
the strains were indistinguishable (Fig. S6 and data not shown). In
addition, we compared LAC wild type and LAC Dselx for a-toxin
and PVL expression levels by ELISA and found identical levels of
expression (data not shown). We then compared the ability of wild
type, mutant and repaired strains to cause lethal necrotizing
pneumonia in a rabbit model [33]. For animals receiving wild type
LAC, all 11 rabbits succumbed within 4 d, compared to 2 of 11
receiving LAC Dselx (p,0.002) (Fig. 6c). Importantly, 4 of 4
rabbits infected with the repaired strain LAC Dselx rep succumbed
within 4 d (Fig. 6c). Body temperatures were recorded in the first
24 h of the experiment, and animals receiving strain LAC
demonstrated significantly higher body temperatures than animals
receiving the SElX-deficient strain LAC Dselx (p,0.002) and LAC
Dselx rep had wild type levels of pyrogenicity (Fig. 6d). On gross
examination, regionally extensive to lobar areas of lung from
rabbits infected with wild type USA300 LAC and the repaired
strain USA300 LAC Dselx rep were dark red to purple, heavy and
oozed blood on the cut surface (Fig. 6e). In contrast, lungs from
rabbits infected with the LAC Dselx mutant strain were reddened
with well demarcated, focal white areas (abscess), but did not show
signs of haemorrhage (Fig. 6e). Histological examination of tissues
from both the wild type USA300 LAC and the repaired strain
USA300 LAC Dselx rep revealed severe haemorrhagic and
necrotising pneumonia (Fig. 6f). Tissue sections from rabbits
infected with the LAC Dselx mutant strain were only moderately
affected (Fig. 6f). Taken together, these data collectively indicate
that SElX made by USA300 LAC causes high fever and
contributes to severity of infection and lethality in a rabbit model
of necrotizing pneumonia.
Discussion
We have identified a novel SAg which is encoded by the great
majority of strains, and which causes lethality in a model of severe
S. aureus human disease. The distribution of selx across the full
breadth of S. aureus diversity, its absence among other staphylo-
coccal species, and its genetic linkage with an integrase
pseudogene suggests an ancient horizontal acquisition event which
happened prior to the most recent common ancestor of the S.
aureus species. The gene is absent from only a single clone
examined (CC30) but the associated integrase pseudogene is
retained suggesting that a deletion event has resulted in the loss of
selx during the evolution of the CC30 lineage. Of note, previous
studies have discovered that the majority of CC30 isolates contain
a SaPI which encodes TSST-1, the most closely-related SAg to
SElX [34,35]. These data imply that virtually all S. aureus isolates
have the capacity to produce either TSST-1 or SElX suggesting an
important role for this sub-group of toxins in S. aureus
pathogenesis.
The selx gene has undergone diversification leading to at least 17
different allelic variants identified among the major clonal lineages
(Fig. 1 b). Although SElX is the first SAg identified which is
encoded in the core genome of S. aureus, the SAgs, SMEZ and
SPEG, are made by the majority of Group A Streptococcal (GAS)
isolates [36]. Extensive allelic variation of SMEZ contributes to
antigenic variation, but does not influence Vb-specificity or
mitogenicity [36]. Whereas GAS is specific for human hosts, S.
aureus is also represented by strains which are specialized for
ruminant or avian host species [37,38]. In contrast to SMEZ,
SElX bovine- and ovine-specific variants displayed distinct Vb
subgroup proliferation profiles for bovine lymphocytes in com-
parison to a human-specific SElX variant suggesting that they
have undergone adaptive diversification leading to enhanced
activity in ruminants. Previously, it was shown that the
proliferation of human and bovine lymphocytes varied in response
to stimulation with allelic variants of the SAg staphylococcal
enterotoxin C (SEC). The SEC bovine variant (SECbov) requires
between 10- and 1000-fold more toxin than SEC1 and the SEC
ovine variant (SECov) to induce proliferation of human or bovine
PBMCs, and results in a distinct Vb-dependent T-cell activation
profile [28,39].
Figure 4. SElX stimulates proliferation of human and rabbit lymphocytes. a) Proliferation of human PBMC cultures with recombinant SElX2,
SElXbov1, and SElXov variants measured by [3H]-thymidine incorporation. Proliferation of human (b) or rabbit (c) PBMC cultures with recombinant
SElX2 (red line) or TSST-1 (black line) measured by [3H]-thymidine incorporation.
doi:10.1371/journal.ppat.1002271.g004
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Figure 5. SElX activates Vb-specific human and bovine Tcells. (ii) Relative fold-change in Vb expression (mean 6 S.E.M.) for human (A) or
bovine (B) T cells after stimulation with (i) SElX2, (ii) SElXbov1, and (iii) SElXov. *indicates statistical significance (p,0.05).
doi:10.1371/journal.ppat.1002271.g005
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Although most of the allelic variation in selx was clonal and due
to point mutation, we found evidence of a role for recombination
in the diversification and distribution of SElX, including whole
gene transfer of the selx allele between pathogenic clones.
Recombination rates are predicted to be low in S. aureus in
general [40], but some recombination, particularly among genes
involved in virulence has been observed [41,42]. Such rapid
evolution may facilitate antigenic or functional diversification of
proteins which are critical for bacterial survival during infection.
Analysis of selx transcription levels revealed a growth phase-
dependent expression analogous to numerous other staphylococcal
virulence proteins which are under the control of agr. Of note, the
human CA-MRSA USA300 strain LAC had relatively high levels
of expression of SElX which correlates with the previously
reported up-regulation of RNAIII and secreted virulence proteins
by the USA300 epidemic clone [43]. In addition to demonstrating
the in vitro expression of SElX by S. aureus strains, we also identified
SElX-specific antibodies in human and ruminant convalescent
serum samples, and in healthy individuals. The high frequency of
sero-conversion to SElX among human and livestock populations
is consistent with the expression of SElX by most commensal and
disease-associated isolates of S. aureus, and imply a broad role for
SElX in S. aureus colonization or infection of multiple host species.
Of particular importance, the USA300 epidemic clone is
currently the primary infectious cause of human mortality in the
USA, and unlike most strains of hospital-associated MRSA can
cause disease in otherwise healthy individuals [44]. The molecular
basis for the increased virulence of USA300 strains has been the
subject of intensive research efforts. Several reports have
highlighted the high levels of expression of secreted proteins such
as Panton-Valentine leukocidin, a-toxin, and phenol-soluble
modulins and evidence exists for a role for each of these toxins
in the pathogenesis of CA-MRSA severe infection [43,45–50].
Recently, Assimacopoulos et al. described an S. aureus extreme
pyrexia syndrome that is associated with CA-MRSA USA300
strains [51]. Our studies suggest that SElX contributes to the
pathogenesis of pulmonary illness caused by these strains, and its
induction of high fever during infection is consistent with a role in
extreme pyrexia syndrome. While most studies on the pathogen-
esis of severe S. aureus pulmonary infections have focused on the
role of cytolysins [43,45,49,50], our data suggest that the novel
SAg SElX may influence the outcome of severe infection caused
by CA-MRSA USA300. This is in agreement with a recent study
that shows that TSST-1, SEB and SEC contribute to lethal
pneumonia of rabbits caused by CA-MRSA USA200 and
USA400 strains [33]. Of note, rabbits are much more similar to
humans than mice in their sensitivity to both SAgs and cytolytic
toxins [52]. Importantly, we have shown that SElX is mitogenic
for both rabbit and human T cells. As the majority of previous
studies into the virulence of S. aureus infections have been carried
out in mice, the importance of SAgs in the pathogenesis of severe
infections may have been underestimated.
Because of the role of SAgs in S. aureus pathogenesis and their
potential as an agent of biological warfare, therapeutic strategies
which target these toxins have been the focus of considerable
research efforts [6]. Structural modeling revealed the potential of
SElX to form the characteristic 2 domain SAg structure joined by
a central a-helix. However domain B of SElX is predicted to be
much smaller than that of other SAgs identified to date (Fig. 4).
Ongoing crystallography analyses should result in important
insights into the molecular interaction of the uniquely structured
SElX with its ligands which may facilitate the design of molecules
to inhibit its function.
CA-MRSA USA300 strains are characterized by high expres-
sion of a number of secreted virulence factors which through direct
activity or immunopathology result in the severe symptoms
associated with infections such as necrotizing pneumonia
[43,45–50]. Here, we report the discovery of a novel secreted
virulence determinant made by most strains of S. aureus that may
contribute to the severity of some human diseases caused by
highly-virulent clones such as CA-MRSA USA300. Furthermore,
the phylogenetic and immunobiological characterization of a
unique S. aureus core genome-encoded SAg provides new insights
into the evolution of pathogenic S. aureus and its capacity to cause
disease in multiple host species.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies. Animal experimentation was performed under a
University ofMinnesota approved Institutional Animal Care and Use
Committee (IACUC) protocol (0908A71722). University of Minne-
sota is accredited by the Association for Assessment and Accreditation
of Laboratory Animal Care International (AALAC). Animals are
maintained in accordance with the applicable portions of the Animal
Welfare Act and the DHHS ‘‘Guide for the Care and Use of
Laboratory Animals’’. In agreement with the University ofMinnesota
IACUC, animals that failed to exhibit escape behaviour and at the
same time could not right themselves were prematurely euthanized.
Animals were euthanized with intravenous injection of 1 ml of
Beuthanasia D, whether prematurely or at the end of experimenta-
tion. Human peripheral blood mononuclear cells were isolated from
heparinized venous blood of four different healthy donors in
accordance with a human subject protocol approved by the
University of Idaho Institutional Review Board for Human Subjects
(approval number 05–056), in accordance with the principles of the
Declaration of Helsinki. Donors were informed the procedure risks
and provided a written consent prior to participation. The University
of Idaho is fully accredited by the AALAC.
S. aureus strains
S. aureus strains were selected to represent clonal genotypes
which represent the breadth of species diversity, different host-
associations and geographic origins (Table S3). S. aureus strains
were grown in tryptone soya broth (TSB) or brain heart infusion
(BHI) broth with shaking at 200 rpm, or on tryptone soya agar
(TSA) plates. For use in animal studies, organisms were cultured in
Todd Hewitt broth or on Todd Hewitt agar. Media was
supplemented where appropriate with chloramphenicol (Sigma-
Aldrich) at 12.5 mg/ml and 150 mg/ml X-gal (5-bromo-4-chloro-
3-indolyl-beta-D-galactopyranoside) (Melford).
Table 2. Human and bovine Vb subfamilies activated in
response to rSElX variants.
SElX variant Human Vb a, b Bovine Vb a, b
SElX2 1, 6, 18, 21 3, 5, 6, 11, 17, 24, X
SElXbov1 1, 6, 18, 21 3, 5, 11, 16, 17, 24, X
SElXov 1, 6, 18 16, 17, 24, X
aVb subfamily nomenclature followed the classification of Arden et al [65].
bBold type indicates subfamilies activated with a significance of p,0.05, and
normal type indicates subfamilies with a trend (p,0.1) towards significant
activation above baseline control (unstimulated).
doi:10.1371/journal.ppat.1002271.t002
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Bioinformatic analyses
The novel putative SAg gene, selx was first identified by BLAST
analysis of the genome of USA300 FPR3757 with the gene sequence
specific for the SAg TSST-1. The sequences of distinct selx alleles
were identified by BLASTn analysis of S. aureus whole genome
sequences deposited in GenBank (Table S1). Additional selx alleles
were sequenced with selxseq primers (Table S2) by Genepool
Sequencing Service (University of Edinburgh, UK), aligned by
ClustalW using MEGA 4.0.1 software [53] and Neighbor-Joining
phylogenetic trees constructed using the Nucleotide Maximum
Composite Likelihood model. At least 500 bootstrap trees were
generated to examine the robustness of the inferred phylogenetic
relationships. Recombination detection program RDP v3.44 was
used to identify putative end points of recombination events [23].
Unique recombination events were detected by at least 3 of the
programs employed by the RDP suite, p,0.05. Protein structural
modeling of the derived amino acid sequences of selx2, selxbov1 and
selxov was carried out. Predicted 3D structures were obtained for
SElX2, SElXbov1 and SElXov with the program Phyre using the
crystal structure of TSST-1 as a template, (PDB file c5tssA) [24].
PDB files were generated for each predicted structure and analyzed
using Pymol software [54]. Amino acid sequence alignment was
carried out using ClustalW and viewed with Jalview [55].
Transcriptional analysis of selx
Total RNA was extracted from S. aureus strains LAC, RF122,
and ED133 exponential (OD600 = 0.6) and stationary phase (16 h)
cultures using the RNeasy miniprep kit (QIAgen) as described in
the manufacturer’s instructions except for re-suspension in TE
buffer with 100 mg/ml Lysostaphin and incubation at 37uC for
20 min. RNA was treated with Turbo DNase (Ambion Inc) and.
0.5 mg mRNA from at least 3 independent total RNA extractions
were reverse-transcribed to cDNA with the Power SYBR Green
RNA-to-CT 2-Step Kit (Applied Biosystems). To quantify cDNA
generated by reverse transcription from target RNA, qRT-PCR
reactions were carried out in 25 ml reactions containing 50 ng of
cDNA, 300 nM selxq or 16S rRNA primers (Table S2), and SYBR
Green I dye master mix (AB), using a Mx3000P light cycler
(Strategene). 16S rRNA primers have been described elsewhere
[56]. Relative values of transcription of selx were determined by
comparative quantification to the internal control 16SrRNA. The
thermal conditions were: 10 min at 95uC for 1 cycle, 20 s at 95uC,
20 s at 60uC and 20 s at 72uC for 40 cycles. RNA samples were
processed in triplicate with no template (NTC), no Reverse
Transcriptase (no RT) and positive genomic DNA controls.
Fluorescence was measured at the end of the annealing phase of
each cycle and a threshold value for the fluorescence set by the
MxPro qPCR software version 4.1.
Cloning and purification of recombinant SAgs
59 primers for cloning selx2, selxbov1, and selxov into the pET15b
plasmid (Novagen), were designed to anneal immediately after the
signal peptide coding region, as predicted by Signal P 3.0 Server
(http://www.cbs.dtu.dk/services/SignalP/), and 39 primers were
designed to include the stop codon of the gene (Table S2). PCR
reactions were carried out using Vent polymerase (NEB) and
contained 100 nM selxpET forward and reverse primers designed
to incorporate restriction sites NdeI and BamHI (Table S2) and
10 ng of template DNA. PCR products were restriction digested
with NdeI and BamHI (NEB), purified, and ligated with T4 DNA
ligase (NEB), and transformed into E. coli DH5a cells. pET
constructs were isolated from DH5a using the QIAprep Spin
Miniprep kit (QIAgen), and transformed into E. coli BL21. BL21
cells containing the pET plasmid constructs were cultured in
Luria-broth containing 50 mg/ml ampicillin (Sigma-Aldrich) and
induced in mid-exponential phase of growth (OD600 = 0.6), with
1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) (ForMe-
dium Ltd.) for 4 h. Cells were recovered by centrifugation at 8000
xg, disrupted using a French Press, and His-tagged recombinant
proteins were purified by affinity chromatography on a Ni-NTA
nickel affinity column (Invitrogen). Proteins were dialysed using
Spectra/Por Float-A-Lyzer tubing with a 8000 to 10000 molecular
weight cut off (MWCO) (Spectrum Laboratories), and LPS was
removed using ProteoSpin endotoxin removal kit (Norgen Biotek).
Western immunoblot analysis
Supernates from stationary phase cultures of S. aureus strains
were concentrated with Amicon Ultra-15 Centrifugal Filter units
(10000 MWCO) (Millipore). Recombinant proteins and concen-
trated secreted proteins were separated by sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to nitrocellulose membranes (Amersham Hybond
ECL, GE Healthcare) in Towbin transfer buffer. The membrane
was incubated in 1 x PBS (pH 7.3) containing 8% powdered milk
(Fluka), at 4uC overnight, washed 3 times with washing buffer, 1 x
PBS (pH 7.3) containing 1% powdered milk and 0.05% Tween 20
(Sigma-Aldrich). The membrane was incubated for 1 h with
primary antibody, which was either a 1:2500 (bovine and ovine) or
1:5000 (human) dilution of serum, or 2 h with 1:1500 dilution of
rat anti-sera raised against rSElXbov1. The membrane was then
incubated with horse radish perixodase conjugated (HRP)
secondary antibodies for 1 h, which was 1:2500 goat anti-bovine
IgG, 1:2500 rabbit anti-sheep IgG, (Santa Cruz Biotechnology),
1:5000 rabbit anti-human IgG (Dako), or 1:1500 goat anti- rat IgG
(Abcam), depending on the experiment. Human sera samples were
obtained from infectious endocarditis patients [57], ovine serum
samples were obtained from experimentally-infected sheep and
provided by E. Vautor [58] and from cows with bovine mastitis by
C. Smyth. Semi-quantitative spot densitometry was carried out
with the ChemiImager 4000i.V4 program, using a MultiImager
light cabinet (Alpha Innotech).
Construction of selx-deficient and selx-repaired
derivatives of S. aureus USA300 LAC
An selx-deficient strain of USA300 LAC was obtained by allele
replacement using the pMAD-CM plasmid [59]. PCR products of
Figure 6. SElX causes TSS and contributes to the severity and lethality of necrotizing pneumonia caused by CA-MRSA USA300. A)
The ability of rSElX2, administered at a dose of 200 mg/kg, to cause TSS was measured using a standard miniosmotic pump model of TSS. TSST-1
administration was used as the positive control and PBS the negative control. B) Fever in response to intravenous injection of rSElX2 at
concentrations of 10 mg/kg (%), 1 mg/kg (&), 0.1 mg/kg (D), of body weight per ml, or PBS (m), was evaluated over a 4 h test period, followed by the
ability to enhance the lethality of LPS over 48 h. C) Kaplan-Meier Curves of % survival of rabbits infected with S. aureus LAC, S. aureus LACDselx, and
LACDselx rep. D). Increase in rabbit core temperature (DT uC) 2 d after pulmonary infection with LAC wt, LACDselx, and LACDselx rep. E). Gross
pathology of lungs from uninfected rabbit (i) or from rabbits infected with LAC wt (ii), LACDselx (iii), and LACDselx rep (iv). F) Haematoxylin Eosin-
stained tissue sections from (i) uninfected rabbit lung, or from rabbit lungs infected with (ii) LAC wt, (iii) LACDselx and (iv) LACDselx rep isogenic
strains.
doi:10.1371/journal.ppat.1002271.g006
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578 bp and 592 bp, flanking the left (AB) and right (CD) regions of
selx, respectively were amplified with primers listed in Table S2. PCR
amplification with primers A and D was carried out with 100 ng of
purified AB and CD template DNA to produce a single spliced AD
fragment by overlapping PCR, facilitated by sequence complemen-
tary to primer B incorporated into the CD fragment by primer C. AD
products were then purified and cloned into the Strataclone pSC-B
plasmid (Stratagene). pSC-B plasmid containing the AD insert was
digested with EcoRI for 3 h at 37uC. The AD fragment was then
purified, ligated into the dephosphorylated gene replacement
plasmid, pMAD-CM , to create pMAD::selx, which was transformed
by electroporation into LAC. LAC containing pMAD::selx was
shaken overnight at 30uC in TSB containing chloramphenicol. To
select for integration of the plasmid into the chromosome through
homologous recombination, 10-fold dilutions were incubated on
TSA containing chloramphenicol at 44uC, a temperature non-
permissive for plasmid replication. Double cross-over excisants were
selected for by growing integrants in TSB without chloramphenicol at
30uC for 24 h. 10-fold dilutions were plated onto TSA containing X-
gal and incubated on TSA at 30uC overnight. White colonies were
screened for antibiotic sensitivity on chloramphenicol plates (inferring
loss of the plasmid) and screened for WT or mutated forms of the
gene by PCR with primers upstream (E) and downstream (Z) of selx
(Table S2). The resulting selx-deficient strain, LACDselx was
sequenced using E and Z primers in order to confirm the in-frame
deletion event. The selx deletion in LACDselx was repaired using an
identical allelic exchange approach employing pMAD-CM. Oligo-
nucleotide primers (Table S2) designed to incorporate a single
synonymous substitution into the selx gene were used to amplify 2
PCR products specific for left and right regions of the selx gene (rep
AB and rep CDprimers). The resulting PCRproducts were spliced to
produce an intact selx gene, and cloned into pMAD as previously
described resulting in pMAD::selx rep. Allelic exchange was carried
out as described for selx mutant construction and the repaired selx
gene sequenced. Western blot analysis confirmed the restoration of
SElX expression (Fig. S6a).
Pyrogenicity, endotoxin enhancement and miniosmotic
pump lethality studies
American Dutch Belted rabbits were injected with rSElX2 at
doses of 10, 1, and 0.1 mg/kg of body weight per ml intravenously.
Three rabbits were injected with each dose and temperature was
measured hourly for 4 h. After 4 h, each rabbit was injected
intravenously with 1 mg of lipopolysaccharide (LPS) from Salmonella
enterica serovar typhimurium (1/500 of the 50% lethal dose of
endotoxin alone). SAgs characteristically amplify the lethal effects of
LPS by up to 106-fold. Lethality was assessed over a 48 h period
[60]. In agreement with the University of Minnesota IACUC,
animals that failed to exhibit escape behaviour and at the same time
could not right themselves were prematurely euthanized. It is our
experience in over 30 years of similar experimentation that this
point is 100% predictive of SAg lethality. Animals were euthanized
with intravenous injection of 1 ml of Beuthanasia D, whether
prematurely or at the end of experimentation. Miniosmotic pumps,
containing 200 mg of rSElX2 or TSST-1, or PBS, were implanted
subcutaneously into 5 American Dutch Belted rabbits per group (3
for TSST-1) [61]. Fever was assessed after 24 h, and lethality of the
toxins over a period of 7 d. The same criteria as above were used for
assessing need for premature euthanasia.
Necrotizing pneumonia rabbit model
Wild-type LAC and the selx knock-out strain were cultured in
Todd Hewitt broth for 16 h and washed once in Todd Hewitt
broth to remove exoproteins. The bacteria were re-suspended in
Todd Hewitt broth at 161010 colony-forming units (CFU)/ml for
use in injections. American Dutch Belted rabbits (11 per group for
LAC wt and LAC Dselx, and 4 for LAC Dselx rep) were
anesthetized with ketamine and xylazine. Their tracheas were
exposed and 26109 USA300 CA-MRSA strain LAC, the isogenic
selx-deficient LAC strain or its repaired derivative were adminis-
tered intra-tracheally through catheters in 0.2 ml volumes. The
animals were closed and monitored for 4 d for development of
fatal necrotizing pneumonia.
Preparation and stimulation of lymphocytes
Blood was obtained from 2 Holstein–Friesian cattle aged 18–
36 m via jugular vein puncture. Animals were reared indoors and
maintained on a ration of hay and concentrates. Peripheral blood
mononuclear cells (PBMC) were isolated from blood by density
gradient centrifugation using Ficoll Paque Plus (GE Healthcare) as
described previously [27,62]. Human PBMC were isolated from
venous blood of 3 healthy donors as described previously [27].
Splenocytes were obtained from American Dutch Belted rabbits as
previously described [63]. Bovine PBMC were adjusted to a
concentration of 16106 cells/ml in complete cell culture medium
(RPMI 1640, Gibco) supplemented with 10% heat-inactivated
FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, 292 mg/ml L-
glutamine (PSG) and 50 mM 2-Mercaptoethanol (Sigma-Aldrich),
and cultured at 37uC, 5% CO2. Human PBMC (1 6 10
6) were
suspended in RPMI 1640 medium (Life technologies) supple-
mented with 2% FBS, 100 U/ml penicillin G, and 100 mg/ml
streptomycin. The cultures were co-incubated with 10-fold
dilutions of rSElX proteins (1 to 1026 mg/ml) for 72 h at 37uC,
5% CO2. After adding [
3H] thymidine (1 mCi), Cells were cultured
for a further 18 h and cellular DNA was harvested on glass fiber
filters. [3H]-thymidine incorporation was quantified by liquid
scintillation counting as described previously [27].
Analysis of Vb-dependent T-cell activation
Total RNA was extracted from human PBMC prior to and after
stimulation with rSElX proteins (1 mg/ml) for 96 h. Expansion of
cells expressing different humVb gene subfamilies was determined
using qRT-PCR as described previously [27]. Total RNA was
extracted from bovine PBMC before and after stimulation with
rSElX variants (1 mg/ml) using Tri-reagent (Sigma–Aldrich). First-
strand cDNA was generated from 0.5 mg of RNA using Power
SYBR Green RNA-to-CT 2-Step Kit (AB). BovVb subfamily-
specific qRT-PCR primers were designed with Primer3 [64],
based on an alignment of bovVb sequences. cDNA sequences for
bovine TRBV genes were derived from the bovine genome and
cDNA analyses described by Connelley et al [29] (Table S2). To
quantify bovVb subfamily gene expression, qRT-PCR reactions
were carried out in 25 ml reactions containing 100ng cDNA, 100
nM primers (Table S2), and SYBR Green I dye master mix (AB)
using a Stratagene Mx3000P light cycler. The thermal conditions
were 1 cycle at 50uC for 10 min, 1 cycle at 95uC for 10 min, 15 s
at 95uC and 1 min at 60uC for 40 cycles. RNA samples were
processed in triplicate with NTC and noRT controls. The
threshold cycle (CT) was determined using MxPro software version
4.1 and normalized to internal controls, b-actin and Constant b
(Cb), by calculating DCT [CT target - CT b-actin- CT (b-actin – Cb)].
Normalized DCT data were then compared by calculating -
DDCT= -(DCT stimulated - DCT of unstimulated). Values .0
indicate expansion of particular subset in response to stimulation.
Statistical analysis
Student’s t-test analysis was used to assess differences in fever
responses in rabbits and differences in humVb and bovVb gene
CA-MRSA Core Genome-Encoded Superantigen
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expression. Fisher’s exact test was used to assess differences in
rabbit survival.
Supporting Information
Figure S1 selx is located in the core genome of S.
aureus. Schematic representation of the genomic context of selx.
selx is depicted in red, the integrase pseudogene is depicted with a
blue arrow, white arrows represent hypothetical proteins of
unknown function and conserved staphylococcal genes are
indicated by black arrows.
(PDF)
Figure S2 Amino-acid sequence alignment of 16 SElX
allelic variants (all alleles except the truncated SElX13).
(PDF)
Figure S3 Identification of predicted recombination
events among selx alleles. Coordinates of beginning break-
points (BB) and end breakpoints (EB) detected by at least 3
different programmes are indicated. Differing filled patterns
indicate gene fragments of distinct evolutionary origin. Colored
outlines and letters indicate different selx alleles.
(PDF)
Figure S4 Phylogenetic tree of selx. A neighbour joining
tree based on selx gene sequences has a distinct topology to a
concatenated multilocus sequence-based tree (Fig. 1b). Bootstrap
values greater than 40 are indicated.
(PDF)
Figure S5 Western blot analysis indicates a lack of
cross-reactivity of SElX antibodies for TSST-1 or SSL7.
Western blot analysis of recombinant SElX TSST-1, SSL7 with
SElX-specific antisera raised in rats and serum samples from
human and ovine infections.
(PDF)
Figure S6 Phenotypic analysis of the LAC Dselx mutant
and LAC Dselx rep. a) Western blot analysis of LAC wt, LAC
Dselx, and LAC Dselx repaired, with SElX-specific antibody. b)
Hemolytic titration of LAC wt, LAC Dselx mutant and LAC Dselx
repaired supernatants incubated with washed rabbit erythrocytes.
Hemolytic titre was determined to be the reciprocal of the dilution
which resulted in ,50% hemolysis (circled in black). c) SDS
PAGE analysis of concentrated supernatant protein fractions
resulted in indistinguishable profiles. In addition, quantification of
a-toxin and PVL levels in LAC wt and LAC Dselx supernatants
revealed identical toxin levels at 3 h, 6 h, 8 h, and 24 h time-
points during growth in CCY medium by specific enzyme-linked
immunosorbent assays (data not shown) (a-toxin, bioMerieux,
Nabi Biopharmaceuticals, and PVL; Besseyre des Horts et al,
Infect Immun. 2010 78:260-4).
(PDF)
Table S1 Distribution and coordinates of selx in
sequenced S. aureus genomes.
(DOC)
Table S2 Oligonucleotide primers used in this study.
(DOC)
Table S3 S. aureus strains employed and selx genotype
and phenotype.
(DOC)
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